premium healthcare products limited Company Information
Company Number
04361934
Next Accounts
Dec 2024
Industry
Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
Shareholders
lalan rubbers (pvt) ltd
lalith prabash hapangama
View AllGroup Structure
View All
Contact
Registered Address
greenwood house greenwood court, bury st edmunds, suffolk, IP32 7GY
premium healthcare products limited Estimated Valuation
Pomanda estimates the enterprise value of PREMIUM HEALTHCARE PRODUCTS LIMITED at £576k based on a Turnover of £167k and 3.45x industry multiple (adjusted for size and gross margin).
premium healthcare products limited Estimated Valuation
Pomanda estimates the enterprise value of PREMIUM HEALTHCARE PRODUCTS LIMITED at £329.3k based on an EBITDA of £46.3k and a 7.11x industry multiple (adjusted for size and gross margin).
premium healthcare products limited Estimated Valuation
Pomanda estimates the enterprise value of PREMIUM HEALTHCARE PRODUCTS LIMITED at £561.8k based on Net Assets of £323.4k and 1.74x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Premium Healthcare Products Limited Overview
Premium Healthcare Products Limited is a live company located in suffolk, IP32 7GY with a Companies House number of 04361934. It operates in the other letting and operating of own or leased real estate sector, SIC Code 68209. Founded in January 2002, it's largest shareholder is lalan rubbers (pvt) ltd with a 64.7% stake. Premium Healthcare Products Limited is a mature, micro sized company, Pomanda has estimated its turnover at £167k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Premium Healthcare Products Limited Health Check
Pomanda's financial health check has awarded Premium Healthcare Products Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
4 Weak
Size
annual sales of £167k, make it smaller than the average company (£800.6k)
- Premium Healthcare Products Limited
£800.6k - Industry AVG
Growth
3 year (CAGR) sales growth of -16%, show it is growing at a slower rate (1.9%)
- Premium Healthcare Products Limited
1.9% - Industry AVG
Production
with a gross margin of 74.3%, this company has a comparable cost of product (74.3%)
- Premium Healthcare Products Limited
74.3% - Industry AVG
Profitability
an operating margin of 27.7% make it less profitable than the average company (37.1%)
- Premium Healthcare Products Limited
37.1% - Industry AVG
Employees
with 1 employees, this is below the industry average (4)
1 - Premium Healthcare Products Limited
4 - Industry AVG
Pay Structure
on an average salary of £30.4k, the company has an equivalent pay structure (£30.4k)
- Premium Healthcare Products Limited
£30.4k - Industry AVG
Efficiency
resulting in sales per employee of £167k, this is equally as efficient (£167k)
- Premium Healthcare Products Limited
£167k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Premium Healthcare Products Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Premium Healthcare Products Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Premium Healthcare Products Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 83 weeks, this is more cash available to meet short term requirements (15 weeks)
83 weeks - Premium Healthcare Products Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 29.5%, this is a lower level of debt than the average (63.1%)
29.5% - Premium Healthcare Products Limited
63.1% - Industry AVG
PREMIUM HEALTHCARE PRODUCTS LIMITED financials
Premium Healthcare Products Limited's latest turnover from March 2023 is estimated at £167 thousand and the company has net assets of £323.4 thousand. According to their latest financial statements, Premium Healthcare Products Limited has 1 employee and maintains cash reserves of £29.2 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 1 | 1 | 2 | 2 | 2 | 4 | 4 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155 | 342 | 529 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 417,000 | 417,000 | 417,000 | 417,000 | 417,000 | 417,000 | 402,000 | 402,000 | 402,000 | 402,000 | 402,000 | 402,000 | 437,000 | 437,000 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 417,000 | 417,000 | 417,000 | 417,000 | 417,000 | 417,000 | 402,000 | 402,000 | 402,000 | 402,000 | 402,000 | 402,155 | 437,342 | 437,529 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31,394 | 36,782 | 28,585 | 20,314 | 9,566 | 18,798 | 19,905 |
Group Debtors | 12,407 | 12,407 | 16,007 | 12,407 | 17,207 | 12,407 | 20,573 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 858 | 967 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 29,156 | 12,278 | 4,372 | 9,477 | 11,083 | 158 | 8,965 | 6,328 | 2,099 | 5,702 | 9,979 | 2,545 | 1,913 | 252 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 41,563 | 24,685 | 20,379 | 21,884 | 28,290 | 13,423 | 30,505 | 37,722 | 38,881 | 34,287 | 30,293 | 12,111 | 20,711 | 20,157 |
total assets | 458,563 | 441,685 | 437,379 | 438,884 | 445,290 | 430,423 | 432,505 | 439,722 | 440,881 | 436,287 | 432,293 | 414,266 | 458,053 | 457,686 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9,674 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 9,538 | 11,241 | 10,939 | 10,274 | 10,274 | 10,274 | 10,174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 10,368 | 0 | 0 | 20,608 | 15,763 | 22,507 | 17,503 | 18,068 | 33,820 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 8,539 | 8,570 | 9,690 | 7,880 | 11,971 | 6,500 | 6,500 | 6,885 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 18,077 | 19,811 | 20,629 | 18,154 | 22,245 | 27,142 | 16,674 | 16,559 | 20,608 | 15,763 | 22,507 | 17,503 | 18,068 | 33,820 |
loans | 117,081 | 125,743 | 137,371 | 149,155 | 159,476 | 169,582 | 180,068 | 190,693 | 155,463 | 165,202 | 180,717 | 194,500 | 204,108 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44,713 | 44,695 | 38,300 | 34,000 | 32,800 | 245,287 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 9,812 | 9,812 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 117,081 | 125,743 | 137,371 | 149,155 | 159,476 | 169,582 | 189,880 | 200,505 | 200,176 | 209,897 | 219,017 | 228,500 | 236,908 | 245,287 |
total liabilities | 135,158 | 145,554 | 158,000 | 167,309 | 181,721 | 196,724 | 206,554 | 217,064 | 220,784 | 225,660 | 241,524 | 246,003 | 254,976 | 279,107 |
net assets | 323,405 | 296,131 | 279,379 | 271,575 | 263,569 | 233,699 | 225,951 | 222,658 | 220,097 | 210,627 | 190,769 | 168,263 | 203,077 | 178,579 |
total shareholders funds | 323,405 | 296,131 | 279,379 | 271,575 | 263,569 | 233,699 | 225,951 | 222,658 | 220,097 | 210,627 | 190,769 | 168,263 | 203,077 | 178,579 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155 | 187 | 187 | 31 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | ||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | -3,600 | 3,600 | -4,800 | 3,942 | -8,275 | -9,854 | -5,388 | 8,197 | 8,271 | 10,748 | -9,232 | -1,107 | 19,905 |
Creditors | 0 | 0 | 0 | 0 | -10,368 | 10,368 | 0 | -20,608 | 4,845 | -6,744 | 5,004 | -565 | -15,752 | 33,820 |
Accruals and Deferred Income | -31 | -1,120 | 1,810 | -4,091 | 5,471 | 0 | -385 | 6,885 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | -9,812 | 0 | 9,812 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 15,000 | 0 | 0 | 0 | 0 | 0 | -35,000 | 0 | 437,000 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | -1,703 | 302 | 665 | 0 | 0 | 100 | 10,174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -8,662 | -11,628 | -11,784 | -10,321 | -10,106 | -10,486 | -10,625 | 35,230 | -9,739 | -15,515 | -13,783 | -9,608 | 204,108 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -44,713 | 18 | 6,395 | 4,300 | 1,200 | -212,487 | 245,287 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | 16,878 | 7,906 | -5,105 | -1,606 | 10,925 | -8,807 | 2,637 | 4,229 | -3,603 | -4,277 | 7,434 | 632 | 1,661 | 252 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -9,674 | 9,674 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 16,878 | 7,906 | -5,105 | -1,606 | 10,925 | -8,807 | 12,311 | -5,445 | -3,603 | -4,277 | 7,434 | 632 | 1,661 | 252 |
premium healthcare products limited Credit Report and Business Information
Premium Healthcare Products Limited Competitor Analysis
Perform a competitor analysis for premium healthcare products limited by selecting its closest rivals, whether from the REAL ESTATE ACTIVITIES sector, other micro companies, companies in IP32 area or any other competitors across 12 key performance metrics.
premium healthcare products limited Ownership
PREMIUM HEALTHCARE PRODUCTS LIMITED group structure
Premium Healthcare Products Limited has no subsidiary companies.
Ultimate parent company
LALAN RUBBERS (PVT) LTD
#0022642
1 parent
PREMIUM HEALTHCARE PRODUCTS LIMITED
04361934
premium healthcare products limited directors
Premium Healthcare Products Limited currently has 4 directors. The longest serving directors include Mr Michael Peck (Nov 2004) and Mr Lalith Hapangama (Jan 2005).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Michael Peck | United Kingdom | 57 years | Nov 2004 | - | Director |
Mr Lalith Hapangama | United Kingdom | 65 years | Jan 2005 | - | Director |
Ahangama Jayatilleke | United Kingdom | 62 years | Nov 2005 | - | Director |
Gayashree Samarakone | United Kingdom | 74 years | Jun 2006 | - | Director |
P&L
March 2023turnover
167k
+16%
operating profit
46.3k
0%
gross margin
74.3%
-0.28%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
323.4k
+0.09%
total assets
458.6k
+0.04%
cash
29.2k
+1.37%
net assets
Total assets minus all liabilities
premium healthcare products limited company details
company number
04361934
Type
Private limited with Share Capital
industry
68209 - Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
incorporation date
January 2002
age
22
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2023
previous names
N/A
accountant
WHITINGS LLP
auditor
-
address
greenwood house greenwood court, bury st edmunds, suffolk, IP32 7GY
Bank
-
Legal Advisor
-
premium healthcare products limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to premium healthcare products limited. Currently there are 2 open charges and 2 have been satisfied in the past.
premium healthcare products limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PREMIUM HEALTHCARE PRODUCTS LIMITED. This can take several minutes, an email will notify you when this has completed.
premium healthcare products limited Companies House Filings - See Documents
date | description | view/download |
---|